High Point Advisor Group LLC Ampio Pharmaceuticals, Inc. Transaction History

High Point Advisor Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $3,600 - $10,575	-22,500 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$1.36 - $2.49 $12,240 - $22,410	-9,000 Reduced 28.57%	22,500 $41,000
Q2 2020 Aug 13, 2020	SELL	$0.47 - $0.72 $2,538 - $3,888	-5,400 Reduced 14.63%	31,500 $19,000
Q1 2020 May 01, 2020	BUY	$0.36 - $0.74 $13,277 - $27,291	36,881 Added 194110.53%	36,900 $19,000
Q1 2020 Apr 27, 2020	SELL	$0.36 - $0.74 $15,797 - $32,471	-43,881 Reduced 99.96%	19 $36.9 Million
Q3 2019 Nov 12, 2019	SELL	$0.38 - $0.52 $570 - $780	-1,500 Reduced 3.3%	43,900 $15,000
Q2 2019 Aug 15, 2019	BUY	$0.39 - $0.7 $17,706 - $31,779	45,400 New	45,400 $18,000
Q1 2019 May 08, 2019	SELL	$0.43 - $0.68 $22,962 - $36,312	-53,400 Closed	0 $0
Q4 2018 Feb 20, 2019	BUY	$0.39 - $0.7 $20,826 - $37,380	53,400 New	53,400 $33,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Point Advisor Group LLC with notifications on news.